Market Access News | pharmaphorum

News

The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher programme.

News

A blood test developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer's more quickly has been approved by the FDA.

News

Kelun-Biotech has picked up another world-first approval for its TROP2-targeting ADC sac-TMT in non-small cell lung cancer.

News

Job losses start at federal agencies, including HHS, but initial reports suggest some workers who have been let go are quickly being reinstated.

News

AstraZeneca has become the second pharma group to reach an agreement with the Trump administration on Most Favoured Nation (MFN) drug pricing.

News

The first stage of AstraZeneca's promised $50 billion investment in US facilities is underway as it breaks ground on a facility in Virginia.